Keros Therapeutics, Inc. KROS
12.00 USD +0.69 (+6.10%)
Regular-session close
12.01 +0.01 +0.08%
After hours · Nov 18, 4:00 PM ET
11.23 Day range 12.40
8.98 52-week range 22.55
- YTD
- -41.06%
- 1 year
- -31.62%
News
globenewswire.com Keros Therapeutics Announces Additional $5 Million Share Repurchase Authorization LEXINGTON, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and…
zacks.com New Strong Buy Stocks for November 12th PANL, CBRL, KROS, NEPH and LRN have been added to the Zacks Rank #1 (Strong Buy) List on November 12, 2026.
